Annual Shareholders Equity
$111.28 M
-$90.08 M-44.74%
31 December 2023
Summary:
Passage Bio annual stockholders equity is currently $111.28 million, with the most recent change of -$90.08 million (-44.74%) on 31 December 2023. During the last 3 years, it has fallen by -$207.37 million (-65.08%). PASG annual shareholders equity is now -65.08% below its all-time high of $318.66 million, reached on 31 December 2021.PASG Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$72.72 M
-$17.84 M-19.70%
30 September 2024
Summary:
Passage Bio quarterly stockholders equity is currently $72.72 million, with the most recent change of -$17.84 million (-19.70%) on 30 September 2024. Over the past year, it has dropped by -$38.57 million (-34.66%). PASG quarterly shareholders equity is now -83.53% below its all-time high of $441.50 million, reached on 31 March 2021.PASG Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PASG Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -34.7% |
| 3 y3 years | -65.1% | -77.2% |
| 5 y5 years | +297.8% | +229.3% |
PASG Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.1% | at low | -77.2% | at low |
| 5 y | 5 years | -65.1% | +297.8% | -83.5% | +229.3% |
| alltime | all time | -65.1% | +297.8% | -83.5% | +229.3% |
Passage Bio Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $72.72 M(-19.7%) |
| June 2024 | - | $90.56 M(-13.7%) |
| Mar 2024 | - | $104.88 M(-5.8%) |
| Dec 2023 | $111.28 M(-44.7%) | $111.28 M(-11.9%) |
| Sept 2023 | - | $126.28 M(-16.0%) |
| June 2023 | - | $150.41 M(-11.7%) |
| Mar 2023 | - | $170.35 M(-15.4%) |
| Dec 2022 | $201.37 M | $201.37 M(-10.3%) |
| Sept 2022 | - | $224.40 M(-9.5%) |
| June 2022 | - | $248.05 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $281.31 M(-11.7%) |
| Dec 2021 | $318.66 M(+4.6%) | $318.66 M(-12.0%) |
| Sept 2021 | - | $362.23 M(-10.0%) |
| June 2021 | - | $402.27 M(-8.9%) |
| Mar 2021 | - | $441.50 M(+44.9%) |
| Dec 2020 | $304.71 M(-641.7%) | $304.71 M(-10.1%) |
| Sept 2020 | - | $338.90 M(-6.7%) |
| June 2020 | - | $363.40 M(-6.0%) |
| Mar 2020 | - | $386.67 M(-787.4%) |
| Dec 2019 | -$56.25 M(+362.1%) | -$56.25 M |
| Dec 2018 | -$12.17 M | - |
FAQ
- What is Passage Bio annual stockholders equity?
- What is the all time high annual shareholders equity for Passage Bio?
- What is Passage Bio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Passage Bio?
- What is Passage Bio quarterly shareholders equity year-on-year change?
What is Passage Bio annual stockholders equity?
The current annual shareholders equity of PASG is $111.28 M
What is the all time high annual shareholders equity for Passage Bio?
Passage Bio all-time high annual stockholders equity is $318.66 M
What is Passage Bio quarterly stockholders equity?
The current quarterly shareholders equity of PASG is $72.72 M
What is the all time high quarterly shareholders equity for Passage Bio?
Passage Bio all-time high quarterly stockholders equity is $441.50 M
What is Passage Bio quarterly shareholders equity year-on-year change?
Over the past year, PASG quarterly stockholders equity has changed by -$38.57 M (-34.66%)